Skip to main content

previous disabled Page of 2
and
  1. No Access

    Chapter

    Burkitt’s lymphoma: Multiparametric analysis of 55 cell lines with special reference to morphometry

    The term ‘Burkitt’s lymphoma’ (BL) connotes a specific morphologic appearance which has been well described [1]. However, the boundaries of this entity from other related B-cell lymphomas, especially the small...

    P. Felman, P. A. Bryon, O. Gentilhomme in Malignant Lymphomas and Hodgkin’s Disease:… (1985)

  2. No Access

    Chapter and Conference Paper

    Conclusions

    The evaluation of the management of NHL in Europe shows that many European groups are today in the favourable position of carrying out clinical research competitive with that of the North-American Study Groups...

    S. Monfardini, B. Coiffier, J. Estapé in The Management of Non-Hodgkin’s Lymphomas … (1990)

  3. No Access

    Chapter and Conference Paper

    Stimulation of Peripheral Blood Progenitor Cells by Chemotherapy and Granulocyte-Macrophage Colony-Stimulating Factor in Lymphoproliferative Diseases

    Hematopoietic progenitor cells can be collected from the peripheral blood, cryopreserved, and reinfused after chemotherapy ablation in cancer patients [1]. The advantage of autografting with circulating progen...

    L. Campos, Y. Bastion, N. Roubi, M. Debost in Cytokines in Hemopoiesis, Oncology, and AI… (1992)

  4. No Access

    Article

    Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring

    Between 1982 and 1991, 41 patients were treated for non HIV related primary cerebral lymphoma (PCL) in our institute. The purpose of this study was to perform a multivariate analysis of prognostic factors for ...

    J-Y Blay, C Lasset, C Carrie, F Chauvin, B Coiffier in British Journal of Cancer (1993)

  5. No Access

    Chapter

    The management of chronic lymphocytic leukemia — a case history

    Chronic lymphocytic leukemia (CLL) is a common lymphoproliferative disease. In Western countries, CLL is the leukemia with the highest incidence among persons aged 50 to 55 years and older. Hallmarks of the di...

    Y. Bastion, N. Dhedin, P. Felman, B. Coiffier in The Teaching Cases from Annals of Oncology (1997)

  6. No Access

    Chapter and Conference Paper

    Follicular Lymphomas: Morphology, Prognostic Factors and Treatment

    Meaningful discussion of therapy of a disease requires a precise definition of the pathologic entity needing therapy. This requirement is only partially fulfilled for the non-Hodgkin’s lymphomas (NHL). Classif...

    B. Coiffier, F. Berger, F. Giles in Interferons (1997)

  7. No Access

    Chapter and Conference Paper

    Alpha-Interferon Role in the Management of Follicular Lymphoma Patients. The GELA Experience

    Follicular lymphomas (FL) represent between 20 and 25% of all lymphomas and are slightly more frequent in America than in Europe and less frequent in Asia [1]. They are composed of follicle center cells, a mix...

    B. Coiffier in Acute Leukemias VII (1998)

  8. No Access

    Article

    Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients

    A prospective study was performed to assess the use of plasma measurement of tumour necrosis factor (TNF), lymphotoxin alpha (LT alpha) and their soluble receptors (p55 and p75) for prognostic risk assignment ...

    K Warzocha, J Bienvenu, P Ribeiro, I Moullet, C Dumontet in British Journal of Cancer (1998)

  9. No Access

    Article

    Mantle cell lymphoma: a retrospective study of 121 cases

    Mantle cell lymphoma (MCL) patients represent a difficult problem, sometimes to establish the diagnosis but mostly because of their refractoriness to standard lymphoma treatments. Which treatments to apply and...

    H Samaha, C Dumontet, N Ketterer, I Moullet, C Thieblemont, F Bouafia in Leukemia (1998)

  10. No Access

    Chapter

    Risk-related treatment strategies for diffuse large B cell lymphoma

    Patients with large cell lymphoma have differing prognoses. Even within a single histologic subtype, outcome is influenced by a number of factors (not all of which are recognized), and the optimal treatment di...

    B. Coiffier in Human Lymphoma: Clinical Implications of the REAL Classification (1999)

  11. No Access

    Chapter

    Optimal treatment strategies for peripheral T cell lymphoma (unspecified category)

    This review combines peripheral “T cell lymphoma, unspecified”, whatever the cell morphology and the specific variants described in the REAL classification [29.1]. If one is going to identify clinical differen...

    B. Coiffier in Human Lymphoma: Clinical Implications of the REAL Classification (1999)

  12. No Access

    Chapter

    Clinical aspects and treatment options of B cell CLL/SLL and immunocytoma

    One of the merits of the REAL classification is that it emphasizes different entities and particularly small lymphocytic and lymphoplasmacytic lymphomas. As noted in a preceding chapter, small lymphocytic lymp...

    B. Coiffier in Human Lymphoma: Clinical Implications of the REAL Classification (1999)

  13. No Access

    Article

    Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurrence of dicentric rearrangements and possible association with adverse outcome

    Unbalanced translocations involving chromosome arm 17p, where the TP53 tumor suppressor gene localizes, are rarely described in chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL), but recent...

    E Callet-Bauchu, G Salles, S Gazzo, C Poncet, D Morel, J Pagès, B Coiffier in Leukemia (1999)

  14. No Access

    Article

    Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin’s lymphoma

    Serum lactic dehydrogenase (LDH) is an important prognostic factor in patients with non-Hodgkin’s lymphoma (NHL). We have examined the LDH isoenzyme content in serum and CSF of patients with NHL, at diagnosis ...

    C Dumontet, J Drai, J Bienvenu, E Neidhardt Berard, C Thieblemont, F Bouafia in Leukemia (1999)

  15. No Access

    Article

    A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors

    Patients with nhl and two or three factors of the international prognostic index (ipi) have a poor prognosis. we performed a prospective trial of intensive induction therapy followed with high-dose consolidati...

    C Dumontet, C Thieblemont, D Espinouse, F Bouafia, O Hequet, G Salles in Leukemia (2000)

  16. No Access

    Article

    Multifocal progressive leukoencephalopathy occurring after refractory anemia and multiple infectious disorders consecutive to severe lymphopenia

    Progressive multifocal leukoencephalopathy (PML) is related to central nervous system infection with JC virus (JCV). This leukoencephalopathy occurs in immunocompromised patients such as those with acquired i...

    O. Hequet, G. Salles, D. Espinousse, C. Dumontet, F. Bouafia in Annals of Hematology (2002)

  17. No Access

    Article

    Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis

    C Thieblemont, K Chettab, P Felman, E Callet-Bauchu, A Traverse-Glehen in Leukemia (2002)

  18. No Access

    Article

    Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

    With the introduction of new drugs such as alpha-interferon (IFN) and purine analogs, the management of hairy cell leukemia (HCL) patients has changed. However, deoxycoformycin (DCF) produced higher complete r...

    F Maloisel, L Benboubker, M Gardembas, B Coiffier, M Divine, C Sebban, M Blanc in Leukemia (2003)

  19. Article

    Open Access

    Impact of epoetin β on quality of life in patients with malignant disease

    This open-label, prospective study was conducted to compare the impact of epoetin β vs standard care on quality of life (QoL) in anaemic patients with lymphoid or solid tumour malignancies. A total of 262 anaemic...

    M Boogaerts, B Coiffier, C Kainz in British Journal of Cancer (2003)

  20. No Access

    Article

    FcγRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)

    S Camilleri-Broët, N Mounier, A Delmer, J Brière, O Casasnovas, L Cassard in Leukemia (2004)

previous disabled Page of 2